Evidence map›Paper›PMID 18202306›Full record

ArticleMolecular pharmacology2008

Dopamine and ethanol cause translocation of epsilonPKC associated with epsilonRACK: cross-talk between cAMP-dependent protein kinase A and protein kinase C signaling pathways.

Lina Yao, Peidong Fan, Zhan Jiang, Adrienne Gordon, Daria Mochly-Rosen, Ivan Diamond

Open access · greenAbstract read
In one paragraph

Article in Molecular pharmacology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Article
  3. Repeated inhibition of sigma-1 receptor suppresses GABAFrontiers in molecular neuroscience · 2022
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Signaling pathways mediating alcohol effects.Current topics in behavioral neurosciences · 2013
    Review
  11. The cellular building blocks of breathing.Comprehensive Physiology · 2012
    Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lina YaoCV Therapeutics, Inc., 3172 Porter Drive, Palo Alto, CA 94304, USA. lina.yao@cvt.com
Peidong Fan
Zhan Jiang
Adrienne Gordon
Daria Mochly-Rosen
Ivan Diamond

Funding

MECHANISMS OF ETHANOL-INDUCED CARDIAC PROTECTIONR01AA011147 · NIAAA · STANFORD UNIVERSITY · PI DARIA MOCHLY-ROSEN · 1996 to 2026
$8.2M
Mechanisms of Ethanol-Induced Cardiac ProtectionR37AA011147 · NIAAA · STANFORD UNIVERSITY · PI MOCHLY-ROSEN, DARIA · 2009 to 2018
$5.3M
CHRONIC EFFECTS OF ETHANOL ON NEURAL CELLS IN CULTURER37AA010030 · NIAAA · ERNEST GALLO CLINIC AND RESEARCH CENTER · PI DIAMOND, IVAN · 1995 to 2004
$3.1M
Ethanol regulation of signaling: from cells to behaviorR01AA010030 · NIAAA · ERNEST GALLO CLINIC AND RESEARCH CENTER · PI DIAMOND, IVAN · 1995 to 2009
$2.4M
NIAAA NIH HHS AA010030-12NIAAA NIH HHS AA11147NIAAA NIH HHS R01 AA010030NIAAA NIH HHS R01 AA011147NIAAA NIH HHS R37 AA010030NIAAA NIH HHS R37 AA011147
6 · The paper itself

Abstract

We found previously that neural responses to ethanol and the dopamine D2 receptor (D2) agonist 2,10,11-trihydroxy-N-propylnorapomorphine hydrobromide (NPA) involve both epsilon protein kinase C (epsilonPKC) and cAMP-dependent protein kinase A (PKA). However, little is known about the mechanism underlying ethanol- and D2-mediated activation of epsilonPKC and the relationship to PKA activation. In the present study, we used a new epsilonPKC antibody, 14E6, that selectively recognized active epsilonPKC when not bound to its anchoring protein epsilonRACK (receptor for activated C-kinase), and PKC isozyme-selective inhibitors and activators to measure PKC translocation and catalytic activity. We show here that ethanol and NPA activated epsilonPKC and induced translocation of both epsilonPKC and its anchoring protein, epsilonRACK to a new cytosolic site. The selective epsilonPKC agonist, pseudo-epsilonRACK, activated epsilonPKC but did not cause translocation of the epsilonPKC/epsilonRACK complex to the cytosol. These data suggest a step-wise activation and translocation of epsilonPKC after NPA or ethanol treatment, where epsilonPKC first translocates and binds to its RACK and subsequently the epsilonPKC/epsilonRACK complex translocates to a new subcellular site. Direct activation of PKA by adenosine-3',5'-cyclic monophosphorothioate, Sp-isomer (Sp-cAMPS), prostaglandin E1, or the adenosine A2A receptor is sufficient to cause epsilonPKC translocation to the cytosolic compartment in a process that is dependent on PLC activation and requires PKA activity. These data demonstrate a novel cross-talk mechanism between epsilonPKC and PKA signaling systems. PKA and PKC signaling have been implicated in alcohol rewarding properties in the mesolimbic dopamine system. Cross-talk between PKA and PKC may underlie some of the behaviors associated with alcoholism.

Indexed as

AnimalsCyclic AMP-Dependent Protein KinasesDopamineEnzyme ActivationEthanolModels, BiologicalProtein Kinase C-epsilonProtein TransportRatsReceptors, Cell SurfaceReceptors for Activated C KinaseSignal TransductionTime FactorsType C PhospholipasesCyclic AMP-Dependent Protein KinasesDopamineEthanolProtein Kinase C-epsilonReceptors, Cell SurfaceReceptors for Activated C KinaseType C Phospholipases

Identifiers

PMID18202306
PMCPMC2692587
OpenAlexW2149183226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.